Han-Yu Cao

7PUBLICATIONS
4CO-AUTHORS
Haematological tumoursMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
Low-Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T-Cell Acute Lymphoblastic Leukemia: A Case Series.

|Jul 11, 2024
Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements.

Han-Yu Cao, Hui-Ying Li, Wen-Zhi Cai

|Dec 12, 2023
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.

Si-Man Huang, Chao-Ling Wan, Han-Yu Cao

|Jan 09, 2023
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome-positive acute myeloid leukemia: A case report.

Si-Man Huang, Tao Tao, Chao-Ling Wan

|Nov 17, 2022
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.

Han-Yu Cao, Chao-Ling Wan, Sheng-Li Xue

|Oct 17, 2022
Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.

Han-Yu Cao, Ling Li, Sheng-Li Xue

Pageof 2

Frequent Collaborators

5 joint publications

Sheng-Li Xue

2 joint publications

Si-Man Huang

1 joint publications

Hai-Ping Dai

1 joint publications

Shen-Hao Liu